Swiss Pharmaceutical Company Roche Receives Emergency Approval from US FDA for COVID-19 Antibody Test
[Asia Economy Reporter Kim Min-young] Swiss pharmaceutical company Roche Holding has received emergency approval from the U.S. Food and Drug Administration (FDA) for a new antibody test for the novel coronavirus infection (COVID-19), Bloomberg News reported on the 3rd (local time).
Roche introduced the new test as the 'Elecsys Anti-SARS-CoV-2' and stated in a press release that it is designed to determine whether a patient has been exposed to the coronavirus and whether antibodies have developed in the body.
Roche explained that this test requires venous blood and through it, will detect the presence of antibodies remaining in the body, including immune antibody immunoglobulin G, which suggests immune potential.
Roche promised to develop an antibody test available by early this month and said it will enter mass production by next month.
The FDA reviewed antibody tests from Abbott Laboratories in the U.S., Becton Dickinson, and DiaSorin from Italy, among others, and Abbott and DiaSorin received emergency approval.
Hot Picks Today
At President Lee's Call to "Give Enough to Shock," Whistleblower Rewards Become a Real Lottery
- If a Samsung Electronics Employee with a 100 Million Won Salary Receives a 600 Million Won Performance Bonus, Taxes Total 247.19 Million Won
- Lived as Family for Over 30 Years... Daughter-in-Law Cast Aside After Husband's Death
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
- Park Minshik Shaves Head: "I Will End Han Donghoon's Predatory and Parasitic Politics"... Ongoing Calls for Conservative Consolidation in Busan Buk-gu Gap within PPP
Earlier, on the 1st (local time), the FDA granted emergency use authorization for remdesivir from Gilead Sciences as a treatment for COVID-19.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
